Polaris Group
TWSE:6550

Watchlist Manager
Polaris Group Logo
Polaris Group
TWSE:6550
Watchlist
Price: 52.4 TWD -0.38% Market Closed
Market Cap: 39.1B TWD
Have any thoughts about
Polaris Group?
Write Note

Polaris Group
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Polaris Group
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Polaris Group
TWSE:6550
Other Equity
NT$381.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Other Equity
ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
28%
CAGR 10-Years
N/A
Tanvex BioPharma Inc
TWSE:6541
Other Equity
-NT$178.4m
CAGR 3-Years
22%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Polaris Group
Glance View

Market Cap
39B TWD
Industry
Biotechnology

Polaris Group engages in the research and development of biotechnology drugs. The firm provides senior care and long-term care with clinical, operational and financial solutions to meet the challenges presented by the long-term-care industry. The firm provides healthcare consulting and staffing solutions. Its healthcare consulting services include Medicare consulting, clinical compliance, mock surveys, analytics, revenue cycle management and additional services. Its staffing solutions include interim staffing, permanent staffing, outsourced MDS coordinators and find a job. The company provides services in ALL 50 states and have a regulatory division to interpret and educate its staff on the state and federal regulations.

Intrinsic Value
3.1 TWD
Overvaluation 94%
Intrinsic Value
Price

See Also

What is Polaris Group's Other Equity?
Other Equity
381.3m TWD

Based on the financial report for Dec 31, 2023, Polaris Group's Other Equity amounts to 381.3m TWD.

What is Polaris Group's Other Equity growth rate?
Other Equity CAGR 1Y
9%

Over the last year, the Other Equity growth was 9%.

Back to Top